Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice

Biomaterials

Volumn 27, Issue 22, 2006, Pages 4157-4164

  Burkatovskaya, Marina ^a   Tegos, George P ^a,b   Swietlik, Emilia ^a,c   Demidova, Tatiana N ^a,d   P Castano, Ana ^a,b   Hamblin, Michael R ^a,b,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Alginate; Antimicrobial; Chitin chitosan; Haemostasis; Infection; Wound dressing

Indexed keywords

BACTERIA; BIOLUMINESCENCE; CELLS; HEALTH CARE; LIGHT SCATTERING; MEDICAL PROBLEMS; PATIENT TREATMENT;

ALGINATE; ANTIMICROBIAL; CHITIN/CHITOSAN; HAEMOSTASIS; INFECTION; WOUND DRESSING;

POLYSACCHARIDES;

ALGINIC ACID; CHITOSAN; SULFADIAZINE SILVER;

ADHESION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BANDAGE; BIOLUMINESCENCE; COMPARATIVE STUDY; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; INOCULATION; LIGHT SCATTERING; MALE; MOUSE; NONHUMAN; OBSERVATION; OPERON; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; TREATMENT OUTCOME; WOUND INFECTION;

ACETATES; ALGINATES; ANIMALS; ANTI-INFECTIVE AGENTS; BANDAGES; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACIDS; MALE; MICE; MICE, INBRED BALB C; OCCLUSIVE DRESSINGS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SILVER SULFADIAZINE; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 33646058317     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.03.028     Document Type: Article

References (29)

1. Poole M.D. Are we facing the end of the antibiotic era?. Ear Nose Throat J 72 (1993) 433
2. Kumar M.N., Muzzarelli R.A., Muzzarelli C., Sashiwa H., and Domb A.J. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104 (2004) 6017-6084
3. Yilmaz E. Chitosan: a versatile biomaterial. Adv Exp Med Biol 553 (2004) 59-68
4. Pusateri A.E., McCarthy S.J., Gregory K.W., Harris R.A., Cardenas L., McManus A.T., et al. Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma 54 (2003) 177-182
5. Rabea E.I., Badawy M.E., Stevens C.V., Smagghe G., and Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 4 (2003) 1457-1465
6. Azad A.K., Sermsintham N., Chandrkrachang S., and Stevens W.F. Chitosan membrane as a wound-healing dressing: characterization and clinical application. J Biomed Mater Res B Appl Biomater 69 (2004) 216-222
7. Di Martino A., Sittinger M., and Risbud M.V. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26 (2005) 5983-5990
8. Aksungur P., Sungur A., Unal S., Iskit A.B., Squier C.A., and Senel S. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Control Release 98 (2004) 269-279
9. Muzzarelli R., Tarsi R., Filippini O., Giovanetti E., Biagini G., and Varaldo P.E. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob Agents Chemother 34 (1990) 2019-2023
10. Kheirabadi B.S., Acheson E.M., Deguzman R., Sondeen J.L., Ryan K.L., Delgado A., et al. Hemostatic efficacy of two advanced dressings in an aortic hemorrhage model in Swine. J Trauma 59 (2005) 25-34
11. Neuffer M.C., McDivitt J., Rose D., King K., Cloonan C.C., and Vayer J.S. Hemostatic dressings for the first responder: a review. Mil Med 169 (2004) 716-720
12. Becker C. Bloodless coup. Funded by the Army, Oregon researchers turn to the sea to develop a revolutionary bandage that stanches heavy bleeding. Mod Healthcare 33 (2003) 30-31
13. Wedmore I., McManus J.G., Pusateri A.E., and Holcomb J.B. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma 60 (2006) 655-658
14. Doyle T.C., Burns S.M., and Contag C.H. In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol 6 (2004) 303-317
15. Demidova T.N., Gad F., Zahra T., Francis K.P., and Hamblin M.R. Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B 81 (2005) 15-25
16. McCarthy SJ, Gregory KW, Morgan JW. Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan. US Patent Application no. 20050147656, 2005.
17. Jett B.D., Hatter K.L., Huycke M.M., and Gilmore M.S. Simplified agar plate method for quantifying viable bacteria. Biotechniques 23 (1997) 648-650
18. Hamblin M.R., O'Donnell D.A., Murthy N., Contag C.H., and Hasan T. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol 75 (2002) 51-57
19. Hamblin M.R., Zahra T., Contag C.H., McManus A.T., and Hasan T. Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis 187 (2003) 1717-1726
20. Gad F., Zahra T., Francis K.P., Hasan T., and Hamblin M.R. Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci 3 (2004) 451-458
21. Francis K.P., Joh D., Bellinger-Kawahara C., Hawkinson M.J., Purchio T.F., and Contag P.R. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 68 (2000) 3594-3600
22. Mobley H.L., and Belas R. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol 3 (1995) 280-284
23. McManus A.T., McLeod Jr. C.G., and Mason Jr. A.D. Experimental Proteus mirabilis burn surface infection. Arch Surg 117 (1982) 187-191
24. Carr H.S., Wlodkowski T.J., and Rosenkranz H.S. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob Agents Chemother 4 (1973) 585-587
25. Monafo W.W., and West M.A. Current treatment recommendations for topical burn therapy. Drugs 40 (1990) 364-373
26. Helander I.M., Nurmiaho-Lassila E.L., Ahvenainen R., Rhoades J., and Roller S. Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. Int J Food Microbiol 71 (2001) 235-244
27. Tsai G.J., and Su W.H. Antibacterial activity of shrimp chitosan against Escherichia coli. J Food Prot 62 (1999) 239-243
28. Thatte H.S., Zagarins S.E., Amiji M., and Khuri S.F. Poly N-acetyl glucosamine-mediated red blood cell interactions. J Trauma 57 (2004) S7-S12
29. Davydova V.N., Yermak I.M., Gorbach V.I., Krasikova I.N., and Solov'eva T.F. Interaction of bacterial endotoxins with chitosan. Effect of endotoxin structure, chitosan molecular mass, and ionic strength of the solution on the formation of the complex. Biochemistry (Mosc) 65 (2000) 1082-1090